OKI-006
OKI-006 is a potent and orally active inhibitor of histone deacetylase (HDAC) . OKI-006 is a unique congener of the natural product HDAC inhibitor largazole. Histone deacetylases (HDACs) play critical roles in epigenomic regulation, and histone acetylation is dysregulated in many human cancers. OKI-006 has the potential for the research of cancer disease[1].
Product Specifications
CAS Number
1315334-23-6
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/oki-006.html
Solubility
10 mM in DMSO
Smiles
SCC/C=C/[C@@H]1CC(NCC2=NC(C(NC(C)(C(N[C@H](C(O1)=O)C(C)C)=O)C)=O)=CS2)=O
Molecular Formula
C21H30N4O5S2
Molecular Weight
482.62
References & Citations
[1]Diamond JR, et al. Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors. Mol Cancer Ther. 2022;21 (3) :397-406.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10356743 96 Well
Mouse Arf GAP with dual PH domain containing protein 2 (CENTA2) ELISA Kit
Sign In for Pricing
View Details 
MBS7014490-01 0.02 mg
Recombinant Rat Fatty acid desaturase 2 (Fads2)
Sign In for Pricing
View Details MBS7014490-02 0.1 mg
Recombinant Rat Fatty acid desaturase 2 (Fads2)
Sign In for Pricing
View Details MBS7014490-03 5x 0.1 mg
Recombinant Rat Fatty acid desaturase 2 (Fads2)
Sign In for Pricing
View Details 